The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 8 May 2006 doi:10.1084/jem.20060028
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 203, Number 5, 1343-1355
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 750K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meresse, B.
Right arrow Articles by Jabri, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meresse, B.
Right arrow Articles by Jabri, B.
Right arrowPubmed/NCBI databases
*GEO DataSet*GEO Profiles
*Substance via MeSH
Medline Plus Health Information
*Celiac Disease
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

Reprogramming of CTLs into natural killer–like cells in celiac disease

Bertrand Meresse1, Shane A. Curran1,5, Cezary Ciszewski1, Gerasim Orbelyan1, Mala Setty2, Govind Bhagat6, Leanne Lee1, Maria Tretiakova1, Carol Semrad3, Emily Kistner4, Robert J. Winchester5, Veronique Braud8, Lewis L. Lanier9, Daniel E. Geraghty10, Peter H. Green7, Stefano Guandalini2, and Bana Jabri1,2,3

1 Department of Pathology, 2 Department of Pediatrics, 3 Department of Medicine, and 4 Department of Health Studies, University of Chicago, Chicago, IL 60637
5 Division of Autoimmune and Molecular Diseases, 6 Department of Pathology, and 7 Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY 10032
8 Institut de Pharmacologie Moleculaire et Cellulaire, Centre National de la Recherche Scientifique/Université de Nice-Sophia Antipolis, UMR6097, 06560 Valbonne, France
9 Department of Microbiology and Immunology, and the Cancer Research Institute, University of California, San Francisco, San Francisco, CA 94143
10 Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109

CORRESPONDENCE Bana Jabri: bjabri{at}bsd.uchicago.edu

Celiac disease is an intestinal inflammatory disorder induced by dietary gluten in genetically susceptible individuals. The mechanisms underlying the massive expansion of interferon {gamma}–producing intraepithelial cytotoxic T lymphocytes (CTLs) and the destruction of the epithelial cells lining the small intestine of celiac patients have remained elusive. We report massive oligoclonal expansions of intraepithelial CTLs that exhibit a profound genetic reprogramming of natural killer (NK) functions. These CTLs aberrantly expressed cytolytic NK lineage receptors, such as NKG2C, NKp44, and NKp46, which associate with adaptor molecules bearing immunoreceptor tyrosine-based activation motifs and induce ZAP-70 phosphorylation, cytokine secretion, and proliferation independently of T cell receptor signaling. This NK transformation of CTLs may underlie both the self-perpetuating, gluten-independent tissue damage and the uncontrolled CTL expansion leading to malignant lymphomas in severe forms of celiac disease. Because similar changes were detected in a subset of CTLs from cytomegalovirus-seropositive patients, we suggest that a stepwise transformation of CTLs into NK-like cells may underlie immunopathology in various chronic infectious and inflammatory diseases.


Abbreviations used: AC, active celiac; EATL, enteropathy-associated T cell lymphoma; GFD, gluten-free diet; IE-CTL, intraepithelial CTL; ITAM, immunoreceptor tyrosine-based activation motif; PB-CTL, peripheral blood CTL.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article

Celiac CTLs change their stripes
Heather L. Van Epps
J. Exp. Med. 2006 203: 1135. [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS